CopyMark Law Group
4.9/5
Drawing for EVID

USPTO serial 87920845

EVID

Reviewed by CopyMark Law Group

Reg. 5642602Status 701Registered
Filing date
Status date
Registration date
Jan 1, 2019
Examiner
MAYES, LAURIE ANN
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with EVID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gabriel M. Gillmeyer

Gabriel M. Gillmeyer Ropes & Gray LLPPrudential Tower, 800 Boylston StreetBoston, MA 02199-3600United States

Goods and services

ClassDescriptionStatusFirst use
042Providing on-line non-downloadable software for research and analysis services for medical and bio-pharmaceutical related purposes; providing on-line non-downloadable software for access to a proprietary search engine, data aggregator, and analysis of search outcomes of medical and bio-pharmaceutical literature and related data sources; providing on-line non-downloadable software for preparation of information reports of medical diseases, including summaries of published findings of the disease analyzed, therapies utilized, outcomes measured, and affected population information; providing on-line non-downloadable software for preparation of information reports of medical and bio-pharmaceutical therapies, including summaries of published findings of the therapy analyzed, diseases treated, outcomes measured, and affected population informationACTIVENov 3, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2025NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Jul 18, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jul 18, 20258.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jul 18, 2025A7OKAMENDMENT UNDER SECTION 7 - PROCESSED—
Jul 15, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 27, 2025ES8RTEAS SECTION 8 RECEIVED—
Feb 27, 2025ES7RTEAS SECTION 7 REQUEST RECEIVED—
Feb 10, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 10, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 10, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 6, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 6, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 6, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 6, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 6, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 6, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 1, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 24, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 15, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 15, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 15, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 1, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 16, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 16, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 26, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 7, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 6, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Sep 6, 2018ALIEASSIGNED TO LIE—
Sep 6, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 6, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 6, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 5, 2018DOCKASSIGNED TO EXAMINER—
May 22, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 17, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance